TOLEROGENICS, INC.

Basic Information

20 NORTH WACKER
SUITE 1201
CHICAGO, IL, 60606-

Company Profile

n/a

Additional Details

Field Value
DUNS: 803391247
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Use of Bispecific Antibody for Treating Non-obese Diabetes

    Amount: $192,679.00

    DESCRIPTION (provided by applicant): Activation of mature T lymphocytes is a multi-step process requiring both Ag-specific triggering of the TCR complex and co-stimulation mediated through the CD28-CD ...

    STTR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government